| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |